Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Both MCUL and HLRCC are caused by a heterozygous mutation in the fumarate hydratase gene. 29527031 2019
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Eleven of the 372 patients with renal cancer were identified to carried pathogenic FH variants associated with HLRCC. 31444830 2020
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE The genetic basis for the hereditary leiomyomatosis and renal cell cancer syndrome is germ-line inactivating mutation in the gene for the Krebs/tricarboxylic acid cycle enzyme, fumarate hydratase (FH), the enzyme that converts fumarate to malate. 19276158 2009
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Mutations of the <i>FH</i> gene have been associated with fumarate hydratase deficiency (FHD), hereditary leiomyomatosis and renal cell cancer (HLRCC), and other diseases. 31522598 2020
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 Biomarker disease BEFREE Ten of the 13 lesions from patients with HLRCC syndrome showed negative FH staining. 27097334 2016
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Inactivating germline mutations in FH cause hereditary leiomyomatosis and renal cell cancer (HLRCC), a cancer syndrome characterised by accumulation of fumarate. 30190474 2018
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Evidence for a founder effect of the germline fumarate hydratase gene mutation R58P causing hereditary leiomyomatosis and renal cell cancer (HLRCC). 17908262 2008
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease CLINVAR
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE The hereditary cancer syndromes hereditary leiomyomatosis and renal cell cancer (HLRCC) and succinate dehydrogenase-related hereditary paraganglioma and pheochromocytoma (SDH PGL/PCC) are linked to germline loss-of-function mutations in genes encoding the Krebs cycle enzymes fumarate hydratase and succinate dehydrogenase, thus leading to elevated levels of fumarate and succinate, respectively<sup>1-3</sup>. 30013182 2018
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Mutations of the tricarboxylic acid cycle enzyme fumarate hydratase cause hereditary leiomyomatosis and renal cell cancer. 27580029 2016
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Similarly, identification of mutations in the fumarate hydratase (FH) gene that lead to a syndrome called hereditary leiomyomatosis and renal cell carcinoma (HLRCC) will impact screening and treatment of women with uterine leiomyomas. 16582132 2006
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Germline mutations of FH, the gene that encodes for the tricarboxylic acid TCA (TCA) cycle enzyme fumarate hydratase, are associated with an inherited form of cancer referred to as Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC). 21695080 2011
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Hereditary leiomyomatosis and renal cell cancer (HLRCC) is caused by autosomal dominant germline mutations in the fumarate hydratase (FH) gene and is characterized by cutaneous leiomyomas, uterine leiomyomas and aggressive renal malignancies. 29423582 2018
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 Biomarker disease BEFREE Early studies of two familial cancer syndromes, the multiple cutaneous and uterine leiomyomatosis (MCUL1), and the hereditary leiomyomatosis and renal cell cancer (HLRCC), implicated FH, a gene on chromosome 1q43 encoding the tricarboxylic acid cycle fumarate hydratase enzyme. 23555580 2013
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 AlteredExpression disease BEFREE This method enables the facile measurement of fumarate hydratase activity in cell and tissue samples, and can be used to detect disruptions in metabolism that underlie the genetic cancer syndrome hereditary leiomyomatosis and renal cell cancer (HLRCC). 31155064 2019
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 AlteredExpression disease BEFREE The overall sensitivity and specificity of absent FH expression in leiomyomas for detection of patients with HLRCC were 70.0% and 97.6%, respectively. 28288038 2017
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 Biomarker disease GENOMICS_ENGLAND SDH mutations establish a hypermethylator phenotype in paraganglioma. 23707781 2013
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant tumor susceptibility syndrome, and the disease-related gene has been identified as fumarate hydratase (fumarase, FH). 26983443 2016
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease UNIPROT Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. 8200987 1994
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed's syndrome). 21051878 2010
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease UNIPROT Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. 11865300 2002
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Heterozygous germline mutations in the FH gene predispose to an aggressive autosomal dominant inherited early-onset kidney cancer syndrome: hereditary leiomyomatosis and renal cell cancer (HLRCC). 28747166 2017
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 Biomarker disease BEFREE FH/2SC immunohistochemistry was informative as all hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas were either FH- or 2SC+. 29410489 2018
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. 20618355 2011
Hereditary Leiomyomatosis and Renal Cell Cancer
0.800 GeneticVariation disease BEFREE Patients with hereditary leiomyomatosis and renal cell carcinoma (HLRCC) resulting from fumarate hydratase (FH) mutations may present with skin, uterine, and renal tumors, with each having unique pathologic features. 28171700 2017